Relationship Between Oral DMT Burden and Adherence in MS
Launched by MONASH UNIVERSITY · Dec 16, 2020
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older.
- • A confirmed diagnosis of multiple sclerosis.
- • Commencement (switching or newly prescribed) of one of the 6 following DMTs within the previous 2-months: cladribine, dimethyl fumarate, fingolimod, teriflunomide, ozanimod, diroximel fumarate.
- • Able to read and write in English.
- • Access to an internet connection and computer facilities, required to complete assessments.
- Exclusion Criteria:
- • Use of any other DMT than cladribine, dimethyl fumarate, fingolimod, teriflunomide, ozanimod, diroximel fumarate.
- • Comorbid neurological condition.
- • Severe cognitive or psychological dysfunction deemed to interfere with the person's ability to undertake study requirements, as determined by their MS clinic treatment team (neurologist; MS nurse).
About Monash University
Monash University, a leading research institution located in Melbourne, Australia, is dedicated to advancing health and medical knowledge through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, Monash University leverages its extensive expertise in fields such as medicine, pharmacy, and biomedical sciences to conduct rigorous, ethically sound research aimed at improving patient outcomes. The university is committed to fostering a research environment that supports the translation of scientific discoveries into practical applications, ensuring that its clinical trials contribute meaningfully to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Melbourne, Victoria, Australia
Patients applied
Trial Officials
Ernest Butler, PhD; MD
Principal Investigator
Monash University; Monash Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials